Evidence map›Paper›PMID 33443119›Full record

ArticleJournal of neurointerventional surgery2021

Health economic impact of first-pass success among patients with acute ischemic stroke treated with mechanical thrombectomy: a United States and European perspective.

Osama O Zaidat, Marc Ribo, Heinrich Paul Mattle, Jeffrey L Saver, Hormozd Bozorgchami, Albert J Yoo, Alexandra Ehm, Emilie Kottenmeier, Heather L Cameron, Rana A Qadeer and 1 more

Abstract read
In one paragraph

Article in Journal of neurointerventional surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Osama O ZaidatDepartment of Neuroscience, Mercy Saint Vincent Medical Center, Toledo, Ohio, USA OOZaidat@Mercy.com.ORCID http://orcid.org/0000-0003-4881-4698
Marc RiboStroke Unit, Neurology, Hospital Vall d'Hebron, Barcelona, Spain.ORCID http://orcid.org/0000-0001-9242-043X
Heinrich Paul MattleDepartment of Neurology, Inselspital, University of Bern, Bern, Switzerland.
Jeffrey L SaverDepartment of Neurology, UCLA, Los Angeles, California, USA.
Hormozd BozorgchamiOregon Health and Science University, Portland, Oregon, USA.
Albert J YooDepartment of Neurointervention, Texas Stroke Institute, Plano, Texas, USA.
Alexandra EhmJohnson & Johnson Medical GmbH, Norderstedt, Germany.
Emilie KottenmeierCerenovus, Johnson & Johnson, Irvine, California, USA.
Heather L CameronEVERSANA, Burlington, Ontario, Canada.
Rana A QadeerEVERSANA, Burlington, Ontario, Canada.
Tommy AnderssonDepartments of Radiology and Neurology, AZ Groeninge, Kortrijk, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFirst-pass effect (FPE), restoring complete or near complete reperfusion (modified Thrombolysis in Cerebral Infarction (mTICI) 2c-3) in a single pass, is an independent predictor for good functional outcomes in the endovascular treatment of acute ischemic stroke. The economic implications of achieving FPE have not been assessed.

objectiveTo assess the economic impact of achieving complete or near complete reperfusion after the first pass.

methodsPost hoc analyses were conducted using ARISE II study data. The target population consisted of patients in whom mTICI 2c-3 was achieved, stratified into two groups: (1) mTICI 2c-3 achieved after the first pass (FPE group) or (2) after multiple passes (non-FPE group). Baseline characteristics, clinical outcomes, and healthcare resource use were compared between groups. Costs from peer-reviewed literature were applied to assess cost consequences from the perspectives of the United States (USA), France, Germany, Italy, Spain, Sweden, and United Kingdom (UK).

resultsAmong patients who achieved mTICI 2c-3 (n=172), FPE was achieved in 53% (n=91). A higher proportion of patients in the FPE group reached good functional outcomes (90-day modified Rankin Scale score 0-2 80.46% vs 61.04%, p<0.01). The patients in the FPE group had a shorter mean length of stay (6.10 vs 9.48 days, p<0.01) and required only a single stent retriever, whereas 35% of patients in the non-FPE group required at least one additional device. Driven by improvement in clinical outcomes, the FPE group had lower procedural/hospitalization-related (24-33% reduction) and annual care (11-27% reduction) costs across all countries.

conclusionsFPE resulted in improved clinical outcomes, translating into lower healthcare resource use and lower estimated costs.

Indexed as

Brain IschemiaIschemic StrokeStrokeHumansRetrospective StudiesStentsThrombectomyTreatment OutcomeUnited Stateseconomicsstrokethrombectomy

Identifiers

PMID33443119
PMCPMC8606461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.